Salarius Pharmaceuticals - through its subsidiary Decoy Therapeutics - is teaming up with the Martinez-Sobrido Lab at Texas Biomed to test novel peptide-conjugate fusion inhibitors across multiple...
Congratulations to Dr. Luis Martinez-Sobrido and his lab on earning two Faculty Oscars: Most Significant Contract Award for arenavirus research and Most Collaborative Faculty. These honors highlight...
Members of the Martinez-Sobrido Lab attended the recent Vaccine Development Center of San Antonio (VDCoSA) conference, where they presented their latest research and connected with colleagues across...
The work of Dr. Luis Martinez-Sobrido's lab is highlighted in Texas Monthly for advancing a universal flu vaccine - aimed at replacing annual shots with long-lasting immunity against all influenza...
Dr. Martinez-Sobrido's pioneering work toward developing a universal influenza vaccine was recently highlighted in the American Lung Association's email newsletter. His research aims to provide broad...
We are thrilled to announce that Dr. Ye has been selected to receive research funding from the American Lung Association. This award recognizes the innovation, strength, and impact of Dr. Ye's project...
The San Antonio Report spotlights Dr. Martinez-Sobrido and his lab's efforts to develop a universal flue vaccine - one that could provide lifelong protection. Their research at Texas Biomed is helping...
In a collaborative step forward, the Martinez-Sobrido Lab at Texas Biomed has entered into an agreement to offer its specialized reverse genetics platform to research partners worldwide. This powerful...
The Fall 2025 Txbiomed Magazine, graduate student Ramya Barre is recognized in the Gratitude section for earning a prestigious fellowship. Her story is part of a broader celebration of the generous...
In celebration of 25 years of safe maximum containment at Texas Biomed, the Fall 2025 TxBiomed Magazine highlights groundbreaking work in BSL-4 - including the Martinez-Sobrido Lab's efforts to combat...
